Expensive specialty drugs are a growing concern that are traditionally overlooked in drug diversion efforts.
Michael Sovie, Executive Vice President of Sales
Advertisement
Articles by Michael Sovie, Executive Vice President of Sales
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Trump Executive Order Recommends Separating MMR Into 3 Shots
2
GLP-1s: A New Frontier in Substance Use Disorder Management
3
First-in-Class RNA Degrader Targets Historically ‘Undruggable’ MYC in Preclinical Multiple Myeloma Models
4
Suzetrigine-Based Multimodal Therapy Enables Opioid-Free Recovery in Patients Receiving Surgery
5